scholarly journals Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

2019 ◽  
Vol 8 (11) ◽  
pp. 5079-5088 ◽  
Author(s):  
Emilie Charton ◽  
Jean‐Baptiste Bachet ◽  
Pascal Hammel ◽  
Jérôme Desramé ◽  
Benoist Chibaudel ◽  
...  
Cancer ◽  
2018 ◽  
Vol 124 (10) ◽  
pp. 2228-2237 ◽  
Author(s):  
Fabio Efficace ◽  
Fausto Castagnetti ◽  
Bruno Martino ◽  
Massimo Breccia ◽  
Mariella D'Adda ◽  
...  

2015 ◽  
Vol 25 (6) ◽  
pp. 1441-1449 ◽  
Author(s):  
Szu-Chun Yang ◽  
Wu-Wei Lai ◽  
Tzuen-Ren Hsiue ◽  
Wu-Chou Su ◽  
Cheng-Kuan Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document